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Clinical profile and predictors of Severe Dengue disease:  
A study from South India 
 
 
Abstract 
Background: Dengue is endemic and prevalent in tropical and sub-tropical countries 
including India and can cause significant mortality and morbidity. There are limited 
studies available on factors associated with severe dengue from India, to investigate the 
predictors of severe dengue in south Indian patients. 
Methods: We recruited 334 patients with dengue admitted in Yashoda Hospital, 
Hyderabad. Study period was between March 2015 and February 2017. Based on clinical 
symptoms, we divided patients into severe dengue and non-severe dengue. Univariate and 
multivariate analysis was performed for prognostic factors of severe dengue. 
Results: Out of 334 patients, there were 186(55.6%) males with mean age 30.3±14.3 39 
years (age range: 10-73 years), severe dengue was seen in 117(35%) and non-severe 
dengue in 217(65%). Clinical symptoms of diabetes, low platelet count (<50,000mm
3
), 
melena, skin rash, delayed admission (>5days after onset) elevated hematocrit, 
lymphadenopathy, hepatomegaly, splenomegaly, convulsions and mortality were 
significantly associated with severe dengue. After multivariate analysis, diabetes (OR: 
2.12; 95% CI:1.34-4.65) (<0.0001), elevated hematocrit (OR: 3.14; 95% CI:2.17-6.14) 
(<0.0001), skin rashes (OR: 1.99; 95% CI: 1.11-3.55) (<0.0001), melena (OR: 2.59; 95% 
CI:1.40-4.93) (<0.0001), low platelet count (OR: 6.71; 95% CI:4.12-13.6) (<0.0001), 
lymphadenopathy (OR: 3.12 95% CI: 1.91-7.85) (<0.0001) and delayed admission (OR: 2.40; 
95% CI:1.31-3.41) (<0.0001) were significantly associated with severe dengue disease. 
Conclusions: In our study, it was established that low platelet count, elevated hematocrit, 
diabetes, skin rash, melena, lymphadenopathy and delayed in admission (>5days) were 
independently associated with severe dengue. 
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Dengue infection has become a common mosquito-borne viral disease, occurs in 
tropical and subtropical countries especially South and Southeast Asia countries, the 
Caribbean, Central and South America, and Africa (1). Worldwide every year, 50-200 
million are affected with dengue infection, with over 20,000 dengue-related deaths and the 
incidence has risen 30 times during the past six decades (2). In India, dengue infection is 
seen all over the country including rural and urban areas (3). Dengue virus belongs to 
Arbovirus group, and infection is characterized by disease, headache, loss of appetite, 
arthralgia, rash, abdominal pain, nausea and vomiting (2). The complication of dengue 
disease was not treated properly, the mortality rate increased more than 20% (1). 
 
Recent 
studies have identified a subset with more complications and high mortality in severe 
dengue compared to non-severe dengue (4).  
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The aim of the study was to investigate the clinical 
symptoms, laboratory findings and mortality in severe 
dengue. Very limited studies are available on this topic from 
Indian subcontinent. 
 
 
Methods  
We prospectively recruited 400 patients with primary 
presumptive diagnosis of dengue and were admitted in the 
Department of Medicine at Yashoda Hospital, Hyderabad 
(figure 1). Yashoda Hospital is a Post-graduate Teaching 
Hospital and a referral center of India, a study period 
between March 2015 and February 2017. Severe dengue was 
defined by World Health Organization (WHO) criteria (3, 5). 
This study was approved by the Institutional Ethics 
Committee (IEC) and consent was obtained from all the 
patients.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Design the flowchart of the patients’ entrance 
 
Out of the 400 patients, 66 patients were excluded 
(twenty seven patients had incomplete data, and 39 patients 
left against medical advice (LAMA) within 3 days of 
admission), remaining 334 patients were included in the 
study. Patients underwent laboratory investigations including 
complete blood test, liver function tests, urine analysis 
(including urine albumin), abdominal ultrasound 
examination, serum creatinine, blood urea, serum albumin, 
serum glucose, cerebrospinal fluid analysis and chest x-ray 
reports were collected.  
In the present study, 120 (35.4%) had hepatic tenderness 
(35.9%), 14 (4.1%) with jaundice, 312(93.4%) had elevated 
liver enzyme, aspartate aminotransferase (AST) ranged 33-
1082 U/L and 29-1028U/L for alanine aminotransferase 
(ALT). 
 Out of 334 dengue patients, 270 had gallbladder (GB) 
wall thickening, 210 with pleural effusion, 179 had ascites, 
and 22(6.5%) subjects were found with splenomegaly and 
hepatomegaly in 26(7.7%) patients. In our patients, there 
were no history of disease like Japanese encephalitis virus 
(JEV), St. Louis encephalitis virus (SLE), West Nile virus 
(WNV) leptospirosis, yellow fever, malaria and hepatitis A, 
B, and C. Twenty (5.9%) patients had electroencephalogram. 
Thirty five (10.4%) patients had brain CT scan, forty patients 
(11.1%) underwent 2D echogram (26 patients had normal 
echocardiography, 10 had <45 of ejection fraction, two 
patients with global hypokinesia, one had pericardial 
effusion and one patient with left ventricular dysfunction), 
magnetic resonance imaging (MRI) was performed on eight 
patients (2.3%).   
Serological examination: In the present study, enzyme-
linked immunosorbent assay (ELISA), specific to dengue, 
IgG and IgM antibody tests were performed in all patients 
(100%) while non-structural protein 1 (NS1) antigen test was 
performed in 140 (41.9%) patients. In our study, cutoff value 
of IgM ≤11, IgG ≤ 22 and NS1 antigen ≤ 11 were negative 
while IgM ≥12, IgG ≥ 23 and NS1 antigen ≥ 12 were 
considered positive.  
Statistical analysis: Statistical analysis was performed using 
SPSS Inc (Statistical Package for the Social Sciences) 16.0 
software. Mean and standard deviation (SD) were calculated. 
The paired t-test was applied for differences in continuous 
variables. Univariate and multivariate analysis was 
performed for potential confounders (diabetics, elevated 
hematocrit, elevated PTT (>1.5) melena, skin rash, delayed 
in admission (>5days), and lymphadenopathy) for sever 
dengue. All tests were two-sided and a p-value <0.05 was 
considered statistically significant. 
 
 
Results 
Out of 334 patients with dengue, 213(63.7%) were men 
with mean age of 30.3±14.3 years and age range of 10-73 
years. Most common symptoms were fever seen in 100%, 
followed by myalgia in 88%, chills in 74.5% nausea/ 
vomiting 65.5% and headache in 38% of patients. On 
clinical examination were severe dengue in 35%, and non-
severe dengue in 64.9%, convulsion was a rare complication 
seen in 4.1% of patients. Elevated hematocrit (>40%) was 
present in 41% and mean platelet count was 0.82±0.67 (table 
1). Among the 334 patients with dengue, IgM positivity was 
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seen in 203 (60.7%), IgG positivity in 73(21.8%), while 
8.9% had both IgM and IgG antibodies positive and 140 
(41.9%) were NS1 antigen test positive patients. 
Delay in admission (>5 days onset) (p<0.0001), low 
platelet count (<50,000 mm
3
) (p<0.0001) melena 
(p<0.0001), skin rash (p<0.0001) lymphadenopathy 
(p<0.0001) elevated hematocrit (p<0.0001), elevated 
PTT(>1.5) (p=0.003), splenomegaly (p<0.0001), convulsion 
(p=0.02), hepatomegaly (p<0.0001), duration in hospital stay 
>5days and mortality (p=0.02) were significantly more 
prevalent in severe dengue compared to non-severe dengue. 
After multivariate analysis, we established that the major 
predictors of severe dengue were diabetes (OR: 2.12; 95% 
CI: 1.34-4.65), elevated hematocrit (OR: 3.14; 95% CI: 2.17-
6.14), melena (OR: 2.59; 95% CI:1.40-4.93) skin rash (OR: 
1.99; 95% CI: 1.11-3.55) delay in admission >5days) (OR: 
2.40; 95% CI:1.31-3.41), low platelet count (<50,000 mm
3
) 
(OR: 6.71; 95% CI:4.12-13.6) headache (OR: 0.99; 95% 
CI:0.51-1.84) and lymphadenopathy (OR:  3.12 95% CI: 
1.91-7.85) (Table 2). 
 
Table 1. Comparison of basal characteristics between severe dengue and non-severe dengue 
 
 Severe dengue 
(includes deaths) 
(n=117) 
Non-severe dengue 
(n=217) 
Total P value 
Men  66(56.4%) 120(55.2%) 186 (55.6%) 0.8 
Women 51(43.5%) 97(44.7%) 148 (44.4%) 0.8 
Mean age (years)  30.4±11.8 30.3±15.4 30.3±14.3 0.9 
Hypertensive  15(12.8%) 18(8.2%) 33 (9.8%) 0.4 
Diabetes  45(38.4%) 37(17%) 82 (24.5%) 0.001 
Delay in admission (>5days )  43(36.7%) 31(14.2%) 74 (22.1%) 0.0001 
Low platelet count(<50,000 mm
3
) 69(58.9%) 23(10.5%) 92 (28.7%) 0.0001 
Chills 79(67.5%) 170(78.3%) 249 (74.5%) 0.1 
Headache 51(43.5%) 76(35%) 127 (38%) 0.0001 
Myalgia 97(82.9%) 197(90.7%) 294 (88%) 0.5 
Arthralgia 49(41.8%) 63(29.8%) 112 (33.5%) 0.09 
Melena 40(34.1%) 33(15.2%) 73 (21.8%) 0.0001 
Rashes 53(45.2%) 50(23%) 103 (30.8%) 0.0001 
Nausea and vomiting 82(70%) 137(63.1%) 219 (65.5%) 0.6 
Abdominal Pain 71(60.6%) 110(50.6%) 181 (54%) 0.1 
Lymphadenopathy 27(23%) 13(5.9%) 40 (11.9%) 0.0001 
Fever >39
0
C 48(41%) 92(42.3%) 140 (41.9%) 0.8 
Elevated hematocrit (>40%) 76(64.9%) 61(28.1%) 137 (41%) 0.0001 
Hypotension 18(15.3%) 20(9.2%) 38 (11.3%) 0.1 
Bradycardia 12(10.2%) 0 12 (3.5%) 0.0001 
Elevated  Plasma Thromboplastin 
Time (>1.5) 
58(49.5%) 67(30.8%) 125 (37.4%) 003 
Splenomegaly 22(18.8%) 0 22 (6.5%) 0.0001 
Convulsions 14(11.9%) 0 14 (4.1%) 0.02 
Hepatomegaly 26(22.2%) 0 26 (7.7%) 0.0001 
Deaths 5(4.2%) 0 5 (1.4%) 0.02 
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Table 2: Predictors of severe dengue 
 
 Univariate Multivariate p value 
 Odds ratio 95% CI Odds ratio 95% CI 
Diabetes 3.04 1.81-5.08 2.12 1.34-4.65 <0.0001 
Elevated hematocrit (>40%) 4.74 2.92-7.67 3.14 2.17-6.14 <0.0001 
Elevated  Plasma Thromboplastin Time (>1.5) 2.20 1.38-3.49 0.91 0.51-1.92 <0.03 
Skin rash 2.76 1.70-4.47 1.99 1.11-3.55 <0.0001 
Melena 3.26 1.72-6.18 2.59 1.40-4.93 <0.0001 
Low platelet count   12.1 6.87-23.3 6.71 4.12-13.6 <0.0001 
Headache  1.45 0.93-2.34 0.99 0.51-1.84 0.04 
Abdominal pain 2.01 1.27-3.19 0.8 0.05-1.91 0.02 
Lymphadenopathy 4.70 2.32-9.54 3.12 1.91-7.85 <0.0001 
Delay in admission (>5days) 2.91 1.82-4.66 2.40 1.31-3.41 <0.0001 
 
 
Discussion  
In our study, we established 35% of severe dengue, other 
studies found similar findings (6-12). Ledika et al. noted 
24.6% in their studies (6),
 
Aung et al. 27.9% (7), Mena-Lora 
et al. 26% (8) of patients with severe dengue. Some studies 
showed the lower prevalence of severe dengue at 9.0% (9). 
The present study revealed no significant association 
between age and severe dengue when dichotomized into <40 
years and above 40 years of age, these findings were 
advocated by others (10). Nonetheless, few studies have 
shown a significant association with young age group (8) 
and older age group (11) with severe dengue. 
There is contradictory evidence regarding the association 
of gender with severity of dengue. In our study, we found no 
significant association of gender with severe dengue (men 
56.4% vs women 43.5%), the similar findings were noted by 
others (10). In contrast, few studies found significant 
association with female gender (12), while others showed 
men to be more prone to develop severe dengue (11). Many 
studies have shown diabetes to be a comorbid factor for 
severe dengue (13). 
 In a study by Saqib et al., 60% of diabetes cases had 
severe dengue (14). In the current study, we established 
independent association of diabetes with severe dengue 
(odds 2.12; 95% CI:1.34-4.65), our finding was supported by 
others (15). The pathophysiology behind diabetes leading to 
severe organ involvement outcome is not well understood 
yet. The innate immunity is already altered in diabetes 
mellitus and results in an existing pro-inflammatory state 
with endothelial dysfunction. Co-occurrence of dengue  
 
 
infection can further worsen the condition with cytokine 
overload, which exaggerates the endothelial damage causing 
vascular leak and dengue hemorrhagic disease predisposing 
to severe dengue (15). Diabetes may also worsen the 
thrombocytopenia in patients with dengue, thus, adding its 
contribution to the development of severe dengue (16). 
The presence of abdominal pain the initial manifestation 
of dengue is now well recognized (4, 17). In our study, we 
found a prevalence of abdominal pain in patients with 
dengue 181 (54.1%) (71 with severe dengue and 94 with  
non-severe dengue), similar findings were recommended by  
others (17). Our study established no significant association 
with severe dengue, a similar finding was noted by Mena 
Lora et al. (8).
 
Nevertheless, Zhang et al. found an 
independent association with abdominal pain (odds: 2.278; 
95% CI: 1.631, 3.182) (4). Hepatomegaly, as a warning 
indication for severe dengue has been suggested by WHO 
(6). In addition, our study found hepatomegaly in 26 (22.2%) 
patients with severe dengue compared to no one in non-
severe dengue, suggesting a high positive predictive value 
(100%) of hepatomegaly in detecting severe dengue, 
similarly a strong association and an independent predictive 
value of hepatomegaly has been advised by others (6).  
Splenomegaly may occur due to viral infection inducing 
inflammatory immune response in patients with dengue and 
showed a strong association with severe dengue (18) while 
others did not (19). The current study showed splenomegaly 
only in patients with severe dengue 22(18.8%) (p<0.0001), 
adding to the data supporting a significant association with 
severe dengue. The most prevalent manifestation was melena 
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in this cohort. Seventy three (21.9%) cases of dengue had 
melena and previous studies showed comparable outcome (4, 
20-23). In the studies of Mohan et al. Laul et al and Mandal 
et al. a prevalence of 19% (20), 26% (21)
 
and
 
26.8% 
respectively they reported (22). In the present study, we 
identified a significantly higher prevalence of melena among 
severe dengue patients (34.1%). On multivariate analysis, we 
found an independent association with severe dengue (odds: 
2.59; 95% CI: 1.40-4.93), our findings were supported by 
other researchers (4).  
Skin rashes are frequently present in dengue disease and 
the present study established an independent association with 
severe dengue (OR: 1.99; 95% CI:1.11-3.55). Our finding 
was supported by Zhang et al. (odds: 2.03; 95% CI:1.26-
3.25) (4) and Khan et al. (OR;9.16; 95% CI:4.04- 20.78) 
(24), while few studies showed no association (23). An 
immunological mechanism may be the explanation for 
developing these rashes. Dengue virus can incite the 
production of cytokines with stimulation of vascular 
endothelial changes, infiltration of mononuclear cells and 
perivascular edema, consequently leading to a skin rash (25). 
The present study showed 23% in lymphadenopathy with 
severe dengue and the previous studies have noted 
lymphadenopathy in 5-40% of patients with severe dengue 
(26). In our study showed lymphadenopathy was found to be 
an independent predictor of severe dengue (OR: 3.12; 95% 
CI: 1.91-7.85). Headache and retro-orbital pain are well-
established symptoms in dengue (26) and are present in 60-
90% of cases with dengue (22).
 
Our study showed no 
significant association of headache with severe dengue. 
These findings were supported by other researchers (4).  
Central nervous system (CNS) features are rare but can occur 
in dengue and in our study, we found convulsion in 14 
(11.9%) patients who were significantly associated with 
severe dengue, our findings were advocated by others (10). 
Seizures can be associated with encephalopathy, 
hemorrhages, infarction or metabolic disorders the may 
effect dengue encephalitis (27) or secondary to 
immunological mechanism (28).  
Elevated hematocrit suggests a vasculopathy along with 
leakage, secondary to increasing vascular permeability is an 
indirect measure of the cytokines being produced and the 
possibility of severe vascular endothelial dysfunction and 
usually predate shock. Recent studies have established 
hematocrit > 40% as a prognostic factor for severe dengue 
(28). Additionally, in our study, hematocrit (≥40%) emerged 
as a strong independent predictor of severe dengue (OR: 
3.14; 95% CI: 2.17-6.14). Nonetheless, a recent study has 
not found any association between elevated hematocrit and 
severe dengue infection in children (29). Thrombocytopenia 
is one of the potential indicators of severe dengue (6). In our 
study, platelet count ≤50,000/ mm3 was significantly higher 
in patients with severe dengue (58.9%) compared to non-
severe dengue (10.5%) (p<0.000).  
The exact pathophysiology of thrombocytopenia in 
dengue is not yet clearly elucidated. Dengue virus may have 
a direct effect on the bone marrow -specially the progenitor 
cells causing a reduction in their capacity to replicate. An 
aberrant immunological response, implicated in severe 
dengue seems to play a significant role by dysregulation of 
plasma-kinin system. This leads to an increased consumption 
of platelets by disseminated intravascular coagulation (DIC). 
The damage is enhanced by increased apoptosis of platelets 
and generation of antiplatelet antibodies (6). Our study 
further emphasizes low platelet count (≤50,000/ mm3) as an 
independent factor for severe dengue (OR: 6.71; 95% CI: 
4.12-13.6). Admission delay was one of the major risk factor 
for severe dengue which may have contributed to death. The 
present study noted delay in admission (≥5days onset) was 
significantly higher among the patients with severe dengue 
43(36.7%) (p<0.0001), our study was advocated by others 
(6, 17). Ledika et al. (6) in his study noted a delay of more 
than 4 days of onset was significantly associated with severe 
dengue. In our study, we established a delay in admission as 
an independent predictor of severe dengue (OR: 2.40; 95% 
CI:1.31-3.41), these findings were supported by other 
researchers (6, 12). Delay in admission in severe cases may 
be due to the administrative issues such as lack of 
knowledge, misdiagnosis or lack of funds. Besides, the 
immunological dysfunction may manifest a couple of days 
after the viral infection itself, resulting in a severe disease, 
eventually getting medical assistance.
  
 
Studies have established the mortality rate of 1-4% in 
severe dengue (30). The present study demonstrated a 
mortality rate of 2.4%. Mortality was significantly associated 
with severe dengue in our study and there was no mortality 
among non-severe dengue patients. Similar studies found a 
case fatality note of 1.2% in severe dengue (6, 7). Severity is 
defined as having more risk of mortality associated with 
severe bleeding, plasma leakage, shock and other organ 
involvement (5).
 
 In our study, we found 5 patients who died 
with elevated transaminase levels and delayed admission (>5 
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days). Three patients had severe bleeding, two with 
convulsions, three patients had concomitant diabetes and 
hypertension. The present study has few limitations: we were 
unable to analyze seasonal variation, rural and urban area 
and quantitative analysis of levels of IgM and IgG antibodies 
against dengue or the glycemic control in diabetic patients 
with severe dengue. The strengths of our study was 
conducted at a single center and a single laboratory to 
confirm dengue. In addition, this study followed current 
WHO guidelines for severe dengue and we did multiple 
regression analysis for predictors of severe dengue.  
In the current study in South Indian population, we 
established that elevated hematocrit (>40%), low platelet 
count (<50,000mm
3
), diabetes, skin rash, melena, 
lymphadenopathy and delay in admission (>5days) were 
independently associated with severe dengue disease. The 
was a low mortality rate (4.2%) in our cohort. Further studies 
to compare the strength of association of these factors can 
help in creating an algorithm for predicting the occurrence of 
severe dengue. 
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